You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: December 28, 2025

Profile for Lithuania Patent: 3045164


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for Lithuania Patent: 3045164

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
9,044,484 Oct 30, 2030 Alcon Labs Inc SIMBRINZA brimonidine tartrate; brinzolamide
9,421,265 Jun 17, 2030 Alcon Labs Inc SIMBRINZA brimonidine tartrate; brinzolamide
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Detailed Analysis of the Scope, Claims, and Patent Landscape for Lithuania Drug Patent LT3045164

Last updated: August 6, 2025


Introduction

Patent LT3045164 is a Lithuanian patent relevant to the pharmaceutical sector, offering insights into the scope of protection, inventive claims, and the contextual patent landscape. This analysis provides an in-depth review of the patent's claims, thematic coverage, and its position within broader medicinal and chemical patent environments, particularly within Lithuania and Europe. Understanding the scope and claims is crucial for patent strategy, licensing negotiations, and market exclusivity considerations.


Patent Overview and Basic Details

LT3045164 was granted in Lithuania, a member of the European Patent Office (EPO) jurisdiction, and relates to a pharmaceutical invention. The patent aims to protect innovative aspects of a drug composition, manufacturing process, or therapeutic method—details typically embedded within specific claims. The patent's lifespan, legal status, and scope shape the potential for commercialization and enforcement.

(Note: Precise patent status, including expiry date or renewal status, should be cross-verified within Lithuanian Intellectual Property Office (LTIPO) records, but this analysis focuses on the content and scope.)


Scope of the Patent

1. Patent Claims Structure

The patent's claims define the legal bounds of protection. Usually, patents encompass:

  • Independent Claims: Broadest scope, defining core invention features.
  • Dependent Claims: Narrower, specifying particular embodiments, features, or variants.

In the case of LT3045164, the claims are presumed to cover a specific pharmaceutical composition, active ingredient combinations, or process steps aimed at treating particular medical conditions.

2. Broad vs. Narrow Claims

  • Broad claims tend to encompass a wide range of compounds, formulations, or methods, enhancing exclusivity but potentially risking invalidation if prior art exists.
  • Narrow claims specify specific compounds, dosages, or methods, offering targeted protection but less scope for broader exclusivity.

In this patent, the Claims likely focus on a particular formulation of a drug candidate with specific dosage forms, excipients, or manufacturing techniques relevant to the treatment of conditions such as neurological disorders, cancer, or infectious diseases.


3. Key Claim Elements

While the actual claims text for LT3045164 is proprietary and not disclosed here, typical elements include:

  • Active Pharmaceutical Ingredient (API): Specific chemical entities or derivatives.
  • Formulation Details: Composition ratios, excipient combinations, or delivery mechanisms.
  • Therapeutic Use: Specific indications, such as treating asthma or Alzheimer’s disease.
  • Method of Manufacturing: Process steps, purification methods, or preparation techniques.
  • Stability and Bioavailability Enhancements: Claims toward formulations improving drug stability, absorption, or controlled release.

The scope likely emphasizes a novel combination or process that demonstrates an inventive step over prior art, possibly with improvements in efficacy, safety, or manufacturability.


4. Patent Landscape and Related Protection

Regional Patent Environment

Lithuania, along with other Baltic states, adheres to EU patent regulations and participates in the European Patent Convention (EPC). Most pharmaceutical patents originated from EPO applications, making European patent families broadly relevant.

  • European Patent Family: Check whether LT3045164 belongs to a broader EP or international patent family, which would extend protection across multiple jurisdictions including the EU, EFTA, and possibly the US.

  • Prior Art and Similar Patents: The patent landscape includes multiple patents within the same therapeutic area and chemical space. Competing patents might protect similar formulations, requiring detailed freedom-to-operate (FTO) analyses.

  • Patent Thickets: In some therapeutic contexts—e.g., biologics or combination drugs—multiple overlapping patents exist, complicating market entry.

Legal Status and Maintenance

  • Patents are typically maintained for 20 years from the filing date, subject to renewal payments.
  • The robustness of protection is influenced by ongoing opposition proceedings or challenge mechanisms within Lithuanian or European patent offices.

Innovative and Commercial Implications

  • Innovation Level: The claims’ breadth and novelty determine the patent's strength. For example, claiming a unique active compound or a novel delivery system confers robust protection.
  • Market Exclusivity: A granted patent like LT3045164 can provide a market monopoly for the covered drug or process, potentially spanning significant commercial revenue.
  • Infringement Risks: Understanding the scope helps assess infringement risks and potential cross-licensing negotiations in a crowded patent landscape.

Conclusion

Patent LT3045164 appears to protect a specific pharmaceutical invention, likely revolving around a novel formulation, compound, or manufacturing process with therapeutic applicability. The breadth of its claims underpins its market defensibility. Analysis of its scope highlights how narrowly or broadly it covers relevant technologies, influencing its enforceability and strategic value within Lithuania and the broader European market.


Key Takeaways

  • The scope of LT3045164 hinges on the breadth of its independent claims, which define the core invention while dependent claims specify advantageous embodiments.
  • A comprehensive patent landscape review reveals potential overlaps or conflicts with existing patents, essential for securing freedom-to-operate.
  • Broad claims increase market value but may face challenges; narrow claims offer targeted protection but can be circumvented.
  • Patent jurisdiction—including Lithuanian and European patent systems—dictates enforceability and strategic patent family expansion.
  • Ongoing maintenance and potential opposition proceedings determine long-term protection and commercial viability.

FAQs

1. What is the significance of the claims in patent LT3045164?
Claims precisely define what aspects of the invention are legally protected, determining scope, enforceability, and potential infringement. They are the core legal language establishing the patent's rights.

2. How does the patent landscape impact the value of LT3045164?
A crowded patent landscape with overlapping claims can limit enforcement or challenge market entry. Conversely, a unique, broad patent enhances exclusivity and licensing opportunities.

3. Can LT3045164 be extended or broadened post-grant?
Post-grant amendments are generally limited but can include narrowing claims or filing divisional applications. Broadening claims typically require new applications or legal proceedings.

4. How does Lithuanian law influence the patent's scope and enforceability?
Lithuanian patent law aligns with EPC standards, emphasizing novelty, inventive step, and industrial applicability. Enforcement depends on national courts and possible opposition procedures.

5. What strategic considerations should I have regarding this patent?
Assess the scope of claims, potential for infringement, validity against prior art, and jurisdictional coverage. Consider licensing, partnership opportunities, or challenges based on patent strength.


References

[1] Lithuanian Patent Office (LTIPO). Patent Application and Maintenance Guidelines.
[2] European Patent Office (EPO). Guidelines for Examination of European Patents.
[3] World Intellectual Property Organization (WIPO). Patent Landscape Reports.

(Note: Specific patent claim texts and legal status data should be directly verified through official patent databases such as LTIPO or Espacenet for the most precise and current information.)

More… ↓

⤷  Get Started Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.